A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

Clinical trial NCT07143968 · RECRUITING

Trial details

NCT number: NCT07143968
Sponsor: Naga P. Chalasani
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease HIV (Human Immunodeficiency Virus)

Start date: 2026-04-23
Primary completion: 2027-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.